To support these molecular effects that GH has on muscle mass, GH receptor knock-out results in a decrease in myofiber CSA and muscle mass loss in mice (Sotiropoulos et al., 2006). It was reported that there is a correlation between acute RE-induced GH increases and long term muscle and fiber type I and II hypertrophy (McCall et al., 1999). These increases in post RE GH levels are blunted in older adults, and a progressive decline in GH secretion and clearance is observed after the age of 40 y (Zaccaria et al., 1999). In contrast, RET in the late part of the follicular phase, when circulating estrogen is enhanced, appears to result in increased fiber type II CSA, nuclei to fiber ratio and muscle mass, compared to RET during luteal phase (Sung et al., 2014; Wikström-Frisén et al., 2017). Although not heavily examined in humans, we review the few studies in the human literature that have examined the role of anabolic hormones on the motoric system. While these studies do not directly indicate that changes in anabolic hormones contribute to reduced human performance in the elderly (e.g., muscle weakness and physical limitations), they do suggest that additional research is warranted along these lines. → MOTS‑c falls under WADA’s Prohibited List, category S2→ Classified alongside "peptide hormones, growth factors, and related substances"→ Banned in- and out-of-competition→ Positive tests may result in disqualification or suspension → First thing in the morning on an empty stomach→ 30–60 minutes before fasted cardio or training→ On non-training days to maintain metabolic signaling MOTS‑c has been shown to increase aerobic performance by enhancing mitochondrial capacity and sparing glycogen during prolonged exercise. The latter is suggested to occur through increased expression of Pax7 and MyoD transcription factors (Thomas et al., 2010; Sambasivan et al., 2011) which induce satellite cell expansion, differentiation, and self-renewal of muscle function and mass (Kitajima and Ono, 2016; Chidi-Ogbolu and Baar, 2019). In addition, estrogen is also known to activate insulin/IGF-1 (Lee et al., 2004) and PI3K/Akt (Mangan et al., 2014) pathways, potentially enhancing the mechanisms regulating MPS (Hansen et al., 2012) and consequently muscle growth (Smith et al., 2014). When testosterone binds to the AR, the AR transforms, dimerizes and translocates to the nucleus, binding to androgen-response elements (ARE) therein, as a homodimer. Therefore, the links between the testosterone response and exercise adaptation in women remain contentious and require further investigation. Moreover, females do not have Leydig cells; the cells which are likely the source of the acute RE-induced increase in testosterone in men (Kvorning et al., 2007). Whilst the majority of investigations into the role of testosterone in muscle adaptive response have been performed in males (reflecting male biology), the importance of circulating concentrations of testosterone in adult women should not be underestimated based on its biological role in the conversion of progesterone to the principal oestrogens—oestradiol and oestrone (Cui et al., 2013). These differences may be important since the duration and magnitude of testosterone and AR elevation and AR exposure to testosterone appear to play a crucial role in skeletal muscle adaptations both in vitro (Bloomer et al., 2000) and in vivo (Antonio et al., 1999; Ferrando et al., 2002). Damage to muscle fibers and proteolysis are significant factors that stimulate muscle mass hypertrophy. The interaction between circulating IGF-1 and its local expression may also play an important role in the regulation of muscle mass. — IGF-1 is synthesized chiefly by hepatocytes and endothelial cells and released into peripheral blood circulation. IGF-1 is produced primarily in the liver as a result of GH stimulation, and participates in GHs' anabolic and myogenic activity. Neuroendocrinology is the branch of biology and medicine that investigates the central nervous systems regulation of endocrine function, with the hypothalamus controlling hormone secretions of the pituitary gland as a partic… Prior to androgen stimulation of skeletal muscle tissue, higher order muscle tissue activation is needed. Historically, androgen signaling was thought to be governed predominately by classical genomic signaling common to steroids and steroid receptors. Steroidogenic enzyme content and T concentrations in skeletal muscle are similar between men and women (17). Testosterone increases lean mass through androgen receptor activation in muscle tissue and modestly reduces total body fat through increased basal metabolic rate. Exogenous GH achieves faster results but at the cost of sustained receptor stimulation, which increases edema and insulin resistance risk. Driven by declining growth hormone secretion, reduced testosterone, and age-related shifts in lipoprotein lipase activity. Io — Endocrinology is the branch of biology and medicine concerned with the endocrine system and its secretions, known as hormones. — This paper points out that there may be a relationship between IGF-1 levels in athletes and inflammatory factors such as IL-6 and IL-1B. GH is released from the pituitary gland and binds to GHR’s in the liver, signaling it to produce and release IGF-1 into blood circulation. The potentiating action occurs when the IGF-1-IGFBP binds to the target cell's ECM components, which results in activation of IGF-1 receptor (IGFR) and then IGF-1 enters the cell and triggers phosphoinositide 3-kinase (P13-K) to generate phosphatidylinositol-bisphosphate (PIP2) (Pinedo-Villanueva et al., 2019), leading to the production of phosphatidylinositol 3,4,5-trisphosphate (PIP3) (O'Neill et al., 2015).